Skip to main content
CCAP
NASDAQ Unknown

Crescent Capital BDC Posts Q2 2026 Net Loss of $(0.09)/Share as NAV Drops to $17.82; Declares $0.34 Dividend

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Asset Management Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$11.23
Mkt Cap
$430.361M
52W Low
$10.64
52W High
$16.035
52W Position info
5.5% above low
Off High info
30% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CCAP is trading near its 52-week low of $10.64 (5.5% above the low).

Summary

Crescent Capital BDC reported a Q2 2026 net loss of $(0.09) per share, weighed down by realized losses and a declining NAV. The company declared a $0.34 regular dividend and a $0.03 special dividend, but rising non-accruals and a 2.5% NAV decline raise concerns about portfolio credit quality.


Key Events · Earnings and Guidance · CCAP

  • Q2 2026 Net Loss

    A net loss of $(0.09) per share was recorded, driven by $(17.7) million in net realized losses and a modest $1.3 million net unrealized gain. Net investment income of $0.36 per share covered the regular dividend.

  • NAV Decline

    Net asset value per share fell to $17.82 from $18.27 at March 31, 2026, a 2.5% sequential decline, reflecting realized losses and portfolio markdowns.

  • Non-Accruals Increase

    Non-accrual investments rose during the quarter, indicating credit stress in the portfolio. The weighted average yield on income-producing securities dipped to 9.6% from 9.8%.

  • Dividend Declarations

    The board declared a Q3 2026 regular dividend of $0.34 per share and the second of three $0.03 special dividends, maintaining the distribution despite earnings pressure.


Analysis · CCAP · Unknown

The Q2 2026 results from Crescent Capital BDC reveal a net loss driven by realized losses and a declining NAV, even though net investment income covered the regular dividend. A rise in non-accrual investments and the NAV's slide from $18.27 to $17.82 point to credit deterioration in the portfolio. While the company continues to return capital through dividends and share repurchases, weakening underlying asset quality could pressure future earnings and distributions.

At the time of this filing, CCAP was trading at $11.23 on NASDAQ in the Unknown sector, with a market capitalization of approximately $430.4M. The 52-week trading range was $10.64 to $16.04. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CCAP - Latest Insights

CCAP
Aug 10, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $11.23 info
Change: $0 (0%) info
Market Cap: $430.361M info
CCAP
Aug 10, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $11.23 info
Change: $0 (0%) info
Market Cap: $430.361M info
CCAP
Jul 01, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $11.10
Real-time Price: $11.23 info
Change: +$0.130 (+1%) info
Market Cap: $430.361M info
CCAP
Jun 24, 2026, 6:27 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.17
Real-time Price: $11.23 info
Change: +$0.060 (+0.54%) info
Market Cap: $430.361M info
CCAP
Jun 24, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.17
Real-time Price: $11.23 info
Change: +$0.060 (+0.54%) info
Market Cap: $430.361M info